Investigational New Drug (IND) Studies | Preclinical Development | Charles River

IND program guide 

For your IND guide and full access to our accelerated reporting timelines, including a full-size Gantt chart, please log in to The Source. If you are not a member of The Source, our new online scientific and educational information center, please click here to register.

For more information about our preclinical capabilities, contact us at 1.877.CRIVER.1 (1.877.274.8371) or askcharlesriver@crl.com.

Discover the full range of Charles River Products and Services
The Source

For more information, contact us at:

1.877.CRIVER.1 (1.877.274.8371)
askcharlesriver@crl.com

view all

News & Events

view all
mai 14 - New Models for Evaluating COPD or ...
mai 11 - Expert Safety Testing to Accelerat...
juin 17-juin 20 -  Noordwijk aan Zee, the Netherlands - 19th MDO Meeting / 12th Europea...
juin 02-juin 05 - Vancouver, British Columbia - CALAS
juin 05-juin 05 - King of Prussia, Pennsylvania - Assessment of Immunomodulation for Bi...
juin 05-juin 08 - Saint Germain sur l’Arbresle, France - Charles River LAL Seminar Seri...
view all
RMS Specialist Montreal, Canada

Charles River Laboratories, Inc.